Patent Assignment
Reel/Frame 059276/0108
Change of Name
Recorded: 2022-03-01
Pages: 2
Assignor
UCB BIOPHARMA SPRL
Executed: 2019-12-02
Assignee
UCB BIOPHARMA SRL
60, ALLÉE DE LA RECHERCHE, BRUSSELS, 1070, BELGIUM
Covered Property
(1)
Anti-Alpha-Synuclein Antibodies
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.